MYL6B expression is significantly upregulated in breast cancer patient blood at 3.42 log2 (TPM+1) compared to 3.06 log2 (TPM+1) in healthy participants’ blood samples (Fig. 11A). This evidence concerns the gene MYL6B and breast carcinoma.